Spark Therapeutics, Inc. - FORM S-1 - XML - IDEA: XBRL DOCUMENT - November 25, 2015

Attached files

file filename
S-1 - FORM S-1 - Spark Therapeutics, Inc.d47302ds1.htm
EX-23.1 - EX-23.1 - Spark Therapeutics, Inc.d47302dex231.htm
v3.3.0.814
Label Element Value
Partners' Capital Account, Unit-based Compensation us-gaap_PartnersCapitalAccountUnitBasedCompensation $ 646,585
Stock Issued During Period Value Convertible Preferred Stock once_StockIssuedDuringPeriodValueConvertiblePreferredStock 10,000,000
Technology and License Agreement [Member]  
Stock Issued During Period, Value, New Issues us-gaap_StockIssuedDuringPeriodValueNewIssues 50,000,000
Retained Earnings [Member]  
Net Income (Loss) Attributable to Parent us-gaap_NetIncomeLoss (57,277,797)
Common Units [Member]  
Partners' Capital Account, Unit-based Compensation us-gaap_PartnersCapitalAccountUnitBasedCompensation $ 646,585
Restricted Stock, Shares Issued Net of Shares for Tax Withholdings us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings 5,870,000
Common Units [Member] | Technology and License Agreement [Member]  
Stock Issued During Period, Value, New Issues us-gaap_StockIssuedDuringPeriodValueNewIssues $ 50,000,000
Stock Issued During Period, Shares, New Issues us-gaap_StockIssuedDuringPeriodSharesNewIssues 25,000,000
Series A Preferred Stock [Member] | Preferred Units [Member]  
Stock Issued During Period Value Convertible Preferred Stock once_StockIssuedDuringPeriodValueConvertiblePreferredStock $ 10,000,000
Stock Issued During Period Shares Convertible Preferred Stock once_StockIssuedDuringPeriodSharesConvertiblePreferredStock 5,000,000

Spark Therapeutics, Inc. Reports